Literature DB >> 17690015

Contribution of myofascial trigger points to migraine symptoms.

Maria Adele Giamberardino1, Emmanuele Tafuri, Antonella Savini, Alessandra Fabrizio, Giannapia Affaitati, Rosanna Lerza, Livio Di Ianni, Domenico Lapenna, Andrea Mezzetti.   

Abstract

UNLABELLED: This study evaluated the contribution of myofascial trigger points (TrPs) to migraine pain. Seventy-eight migraine patients with cervical active TrPs whose referred areas (RAs) coincided with migraine sites (frontal/temporal) underwent electrical pain threshold measurement in skin, subcutis, and muscle in TrPs and RAs at baseline and after 3, 10, 30, and 60 days; migraine pain assessment (number and intensity of attacks) for 60 days before and 60 days after study start. Fifty-four patients (group 1) underwent TrP anesthetic infiltration on the 3rd, 10th, 30th, and 60th day (after threshold measurement); 24 (group 2) received no treatment. Twenty normal subjects underwent threshold measurements in the same sites and time points as patients. At baseline, all patients showed lower than normal thresholds in TrPs and RAs in all tissues (P < .001). During treatment in group 1, all thresholds increased progressively in TrPs and RAs (P < .0001), with sensory normalization of skin/subcutis in RAs at the end of treatment; migraine pain decreased (P < .001). Threshold increase in RAs and migraine reduction correlated linearly (.0001 < P < .006). In group 2 and normal subjects, no changes occurred. Cervical TrPs with referred areas in migraine sites thus contribute substantially to migraine symptoms, the peripheral nociceptive input from TrPs probably enhancing the sensitization level of central sensory neurons. PERSPECTIVE: This article shows the beneficial effects of local therapy of active myofascial trigger points (TrPs) on migraine symptoms in patients in whom migraine sites coincide with the referred areas of the TrPs. These results suggest that migraine pain is often contributed to by myofascial inputs that enhance the level of central neuronal excitability.

Entities:  

Mesh:

Year:  2007        PMID: 17690015     DOI: 10.1016/j.jpain.2007.06.002

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  25 in total

1.  Painful scalp arteries in migraine.

Authors:  Carlo Cianchetti; Maria Giuseppina Ledda; Maria Celeste Serci; Francesco Madeddu
Journal:  J Neurol       Date:  2010-05-09       Impact factor: 4.849

2.  Dry needling for the management of thoracic spine pain.

Authors:  César Fernández-de-Las-Peñas; Michelle Layton; Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2015-07

Review 3.  Myofascial trigger points: peripheral or central phenomenon?

Authors:  César Fernández-de-las-Peñas; Jan Dommerholt
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

4.  An Exploratory Study to Determine the Relationship between Cervical Dysfunction and Perimenstrual Migraines.

Authors:  Simone Horwitz; Aimee Stewart
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

Review 5.  Myofascial Head Pain.

Authors:  César Fernández-de-Las-Peñas
Journal:  Curr Pain Headache Rep       Date:  2015-07

6.  Chronic daily headache: suggestion for the neuromuscular oral therapy.

Authors:  H Didier; C Marchetti; G Borromeo; V Tullo; D D'amico; G Bussone; F Santoro
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

7.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

8.  Update on Medication-Overuse Headache and Its Treatment.

Authors:  Maria Adele Giamberardino; Dimos-Dimitrios Mitsikostas; Paolo Martelletti
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

Review 9.  The role of extraocular and facial muscle trigger points in cephalalgia.

Authors:  Cristin A McMurray; Zahid H Bajwa
Journal:  Curr Pain Headache Rep       Date:  2008-10

Review 10.  Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Martina Curto; Andrea Negro; Raffaele Costantini; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2016-06-23       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.